Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. 1989

R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
Department of Diagnostic Radiology, University of Kansas Medical Center, Kansas City.

Two hundred and two patients with bone pain from metastatic cancer were treated with 40 microCi/kg of Sr-89. Patients were followed with pain diaries, records of medication taken, sleep patterns, serial bone scans and a Karnofsky Index. One hundred and thirty-seven patients with adequate followup survived at least 3 months, including 100 with prostate and 28 with breast carcinoma. Eighty of the 100 patients with prostate cancer responded, and 25 of the 28 breast cancer patients improved. Ten patients with prostate cancer and five with breast cancer became pain free. Little hematologic depression was noted. Sr-89 kinetic studies showed that strontium taken up in osteoblastic areas remained for 100 days. The tumor-to-marrow absorbed dose ratio was 10:1.

UI MeSH Term Description Entries
D008297 Male Males
D010148 Pain, Intractable Persistent pain that is refractory to some or all forms of treatment. Refractory Pain,Intractable Pain,Intractable Pains,Pain, Refractory,Pains, Intractable,Pains, Refractory,Refractory Pains
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013326 Strontium Radioisotopes Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes. Radioisotopes, Strontium

Related Publications

R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
June 1993, American family physician,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
April 1996, Oncology nursing forum,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
November 2022, Journal of bone and mineral metabolism,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
January 1994, European urology,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
May 1999, Nederlands tijdschrift voor geneeskunde,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
November 2000, BJU international,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
January 1996, The Hospice journal,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
July 2000, Nuclear medicine communications,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
January 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
R G Robinson, and G M Blake, and D F Preston, and A J McEwan, and J A Spicer, and N L Martin, and A V Wegst, and D M Ackery
January 1997, Tumori,
Copied contents to your clipboard!